Saiz-Masvidal, C, De la Peña-Arteaga, V, Bertolín, S, Diez, I, Juaneda-Seguí, A, Martínez-Zalacaín, I, Chavarría-Elizondo, P, Subirà, M, Menchón, JM, Sepulcre, J, Fullana, MA, Soriano-Mas, C. Mapping cross-modal functional connectivity of major neurotransmitter systems in the human brain. Brain Structure & Function. 2025; 230(7)DOI:10.1007/s00429-025-02996-4. PMID:40828212. IF:2.900(Q1/1D).

Martinez, C, Feliu, A, Saura, J, Nieva, G, Pinet, C, Raich, A, Mondon, S, Barrio, P, Andreu, M, Hernández-Ribas, R, Costa, S, Suelves, JM, Vilaplana, J, Enriquez, M, Alaustre, L, Vilalta, E, Alvarez, JB, Guydish, J, Fernández, E, Ballbè, M. Effectiveness of a Post-discharge Phone-Based Smoking Cessation Intervention for Patients with Severe Mental Health Disorders: The 061 Quitmental Randomized Controlled Clinical Trial. International Journal of Mental Health and Addiction. 2025; 23(4)DOI:10.1007/s11469-024-01254-8. PMID:40936741. IF:2.500(Q2/4D).

Gil-Berrozpe, GJ, Segura, AG, Sánchez-Torres, AM, Amoretti, S, Giné-Servén, E, Vieta, E, Mezquida, G, Lobo, A, Gonzalez-Pinto, A, Andreu-Bernabeu, A, Roldán, A, Forte, MF, Castro, J, Bergé, D, Rodríguez, N, Ballesteros, A, Mas, S, Cuesta, MJ, Bernardo, M. Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 92DOI:10.1016/j.euroneuro.2024.12.002. PMID:39721378. IF:6.700(Q1/1D).

Young, AH, Llorca, PM, Fagiolini, A, Falkai, P, Cardoner, N, Nielsen, RE, Blomqvist, O, Godinov, Y, Rive, B, Diels, J, Mulhern-Haughey, S, Reif, A. Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial. BRITISH JOURNAL OF PSYCHIATRY. 2025; 226(2)DOI:10.1192/bjp.2024.124. PMID:39618237. IF:7.600(Q1/1D).